Picard Medical is trading 6.58% up at $4.70, following broad market relief after August CPI matched forecasts.

  • The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average are each up more than 0.5%, supporting a global risk-on explanation.
  • No fresh company-specific announcement or clear new catalyst was identified for September 11, 2026; available coverage indicates limited recent news for the stock.